Affinity DataKi: 0.0270nMAssay Description:Inhibitory concentration of the compound against trypsin.More data for this Ligand-Target Pair
Affinity DataKi: 0.0350nMAssay Description:Compound was evaluated for its binding affinity to the thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.0710nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataKi: 0.0730nMAssay Description:Inhibitory concentration of the compound against trypsin.More data for this Ligand-Target Pair
Affinity DataKi: 0.0730nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataKi: 0.200nMAssay Description:Compound was evaluated for its binding affinity to the thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.230nMAssay Description:Inhibitory concentration of the compound against trypsin.More data for this Ligand-Target Pair
Affinity DataKi: 0.280nMAssay Description:Compound was evaluated for its binding affinity to the trypsin enzymeMore data for this Ligand-Target Pair
Affinity DataKi: 0.300nMAssay Description:Compound was evaluated for its binding affinity to the thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 0.310nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataKi: 0.430nMAssay Description:Compound was evaluated for its binding affinity to the trypsin enzymeMore data for this Ligand-Target Pair
Affinity DataKi: 0.450nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataKi: 0.640nMAssay Description:Inhibitory concentration of the compound against trypsin.More data for this Ligand-Target Pair
Affinity DataKi: 0.650nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataKi: 0.850nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataKi: 0.850nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataKi: 1.60nMAssay Description:Compound was evaluated for its binding affinity to the thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 1.90nMAssay Description:Compound was evaluated for its binding affinity to the thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 2.40nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataKi: 4.30nMAssay Description:Compound was evaluated for its binding affinity to the thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 5.10nMAssay Description:Compound was evaluated for its binding affinity to the thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 5.90nMAssay Description:Compound was evaluated for its binding affinity to the tryptaseMore data for this Ligand-Target Pair
Affinity DataKi: 18nMAssay Description:Compound was evaluated for its binding affinity to the thrombinMore data for this Ligand-Target Pair
Affinity DataKi: 21nMAssay Description:Compound was evaluated for its inhibitory activity against KallikreinMore data for this Ligand-Target Pair
Affinity DataKi: 31nMAssay Description:Compound was evaluated for its inhibitory activity against KallikreinMore data for this Ligand-Target Pair
Affinity DataKi: 106nMAssay Description:Compound was evaluated for the inhibition of Tissue type plasminogen activator (tissue plasminogen activator)More data for this Ligand-Target Pair
Affinity DataKi: 140nMAssay Description:Inhibitory concentration of the compound against coagulation factor VIIaMore data for this Ligand-Target Pair
Affinity DataKi: 165nMAssay Description:Inhibitory concentration of the compound against Coagulation factor XaMore data for this Ligand-Target Pair
Affinity DataKi: 200nMAssay Description:Inhibitory concentration of the compound against coagulation factor VIIaMore data for this Ligand-Target Pair
Affinity DataKi: 385nMAssay Description:Inhibitory concentration of the compound against Coagulation factor XaMore data for this Ligand-Target Pair
Affinity DataKi: 508nMAssay Description:Inhibitory concentration of the compound against Urokinase-type plasminogen activatorMore data for this Ligand-Target Pair
Affinity DataKi: 632nMAssay Description:Inhibitory concentration of the compound against Tissue type plasminogen activatorMore data for this Ligand-Target Pair
Affinity DataKi: 699nMAssay Description:Inhibitory concentration of the compound against plasminMore data for this Ligand-Target Pair
Affinity DataKi: 927nMAssay Description:Inhibitory concentration of the compound against Urokinase-type plasminogen activatorMore data for this Ligand-Target Pair
Affinity DataKi: 978nMAssay Description:Inhibitory concentration of the compound against plasminMore data for this Ligand-Target Pair
Affinity DataKi: 2.00E+3nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataIC50: 1nMAssay Description:Inhibition of phospho-p38 alpha activity by ELISAMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: <1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 1nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
Affinity DataIC50: 1.20nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataIC50: 1.5nMAssay Description:Inhibitory concentration of the compound against thrombin.More data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibition of phospho-p38 alpha activity by ELISAMore data for this Ligand-Target Pair
Affinity DataIC50: 2nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 2nMAssay Description:Inhibitory activity against human recombinant arginine vasopressin V2 receptor using [3H]-AVP as radioligand in CHO cellsMore data for this Ligand-Target Pair
TargetVasopressin V1a/V1b receptor(Homo sapiens (Human))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in human plateletMore data for this Ligand-Target Pair
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V1 receptor using [3H]AVP as radioligand in rat liverMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair
TargetVasopressin V2 receptor(Rattus norvegicus (Rat))
Central Pharmaceutical Research Institute
Curated by ChEMBL
Central Pharmaceutical Research Institute
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibitory activity against arginine vasopressin V2 receptor using [3H]-AVP as radioligand in rat adrenal medullaMore data for this Ligand-Target Pair